Immunological and virological benefits resulted from short-course treatment during primary HIV infection: a meta-analysis (Q35064203)

6 August 2017

0 references

Immunological and virological benefits resulted from short-course treatment during primary HIV infection: a meta-analysis (English)

1 reference

6 August 2017

0 references

Jingjing Chen

1

1 reference

6 August 2017

Xiaoxu Han

2

1 reference

6 August 2017

Minghui An

3

1 reference

6 August 2017

Jing Liu

4

1 reference

6 August 2017

Junjie Xu

5

1 reference

6 August 2017

Wenqing Geng

6

1 reference

6 August 2017

Yangtao Ji

7

1 reference

6 August 2017

Hong Shang

8

1 reference

6 August 2017

language of work or name

English

0 references

publication date

6 December 2013

1 reference

6 August 2017

1 reference

6 August 2017

volume

8

1 reference

6 August 2017

issue

12

1 reference

6 August 2017

page(s)

e82461

1 reference

Creative Commons Attribution 4.0 International

6 August 2017

copyright license

start time

6 December 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Universal antiretroviral therapy for HIV infection: should US treatment guidelines be applied to resource-limited settings?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855754

Short-course antiretroviral therapy in primary HIV infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855754

No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855754

The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855754

Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855754

Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855754

Transient lowering of the viral set point after temporary antiretroviral therapy of primary HIV type 1 infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855754

The immune response during acute HIV-1 infection: clues for vaccine development

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855754

Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855754

Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohort

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855754

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855754

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855754

Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855754

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855754

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855754

Rapid CD4+ cell decrease after transient cART initiated during primary HIV infection (ANRS PRIMO and SEROCO cohorts).

8 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082461

The effect of antiretroviral treatment of different durations in primary HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082461

A controlled trial of zidovudine in primary human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082461

A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082461

Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082461

Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082461

Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082461

High frequency of highly active antiretroviral therapy modifications in patients with acute or early human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082461

Recent changes in the management of primary HIV-1 infection: results from the French PRIMO cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082461

Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3855754

Immune control of HIV-1 after early treatment of acute infection

27 September 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082461

Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: findings from an observational cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0082461

Effect of transient antiretroviral treatment during acute HIV infection: comparison of the Quest trial results with CASCADE natural history study

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/24324793

12 December 2020

Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/24324793

12 December 2020

Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions

1 reference

https://pubmed.ncbi.nlm.nih.gov/24324793

12 December 2020

Estimating the benefit of an HIV-1 vaccine that reduces viral load set point

1 reference

https://pubmed.ncbi.nlm.nih.gov/24324793

12 December 2020

Does transient HAART during primary HIV-1 infection lower the virological set-point?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24324793

12 December 2020

10.1371/JOURNAL.PONE.0082461

Identifiers

DOI

1 reference

6 August 2017

0 references

1 reference

6 August 2017

1 reference